CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event.
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Chiva-Blanch, Gemmaca
- dc.contributor.author Suades Soler, Rosa, 1984-ca
- dc.contributor.author Crespo, Javierca
- dc.contributor.author Vilahur, Gemmaca
- dc.contributor.author Arderiu, Gemmaca
- dc.contributor.author Padró, Teresaca
- dc.contributor.author Corella, Doloresca
- dc.contributor.author Salas-Salvadó, Jordica
- dc.contributor.author Arós, Fernandoca
- dc.contributor.author Martínez-González, Miguel Ángel, 1957-ca
- dc.contributor.author Ros, Emilioca
- dc.contributor.author Fitó Colomer, Montserratca
- dc.contributor.author Estruch, Ramónca
- dc.contributor.author Badimón, Lina, 1953-ca
- dc.date.accessioned 2016-07-19T09:47:33Z
- dc.date.issued 2016
- dc.description.abstract Circulating microparticles (cMPs) are phospholipid-rich blebs of 0.1–1.0 μm in size shed from the plasma membrane of eukaryotic cells when injured, activated, or undergoing apoptosis. MPs have been shown to reflect cellular activation and/or tissue degeneration occurring in vivo.ca
- dc.description.sponsorship GC-B is a Sara Borrell Postdoctoral Fellow (CD13/00023) from Instituto de Salud Carlos III. This work has been possible thanks to funding received from Spanish Ministry of Economy and Competitiveness (Plan Estatal de I + D + I 2013–2016, SAF2013-42962-R, to LB), from the Cardiovascular Research Network of Instituto de Salud Carlos III (RIC, RD12/0042/0027 to LB; SAF2012-40208 to GV) and from CIBER CB06/03 Fisiopatología de la Obesidad y la Nutrición of Instituto de Salud Carlos III, (CIBERobn, RD06/0045 to RE). JS-S and RE thank the Fundació la Marató TV3. CIBEROBN is an initiative of ISCIII, Spain.
- dc.format.mimetype application/pdfca
- dc.identifier.citation Chiva-Blanch G, Suades R, Crespo J, Vilahur G, Arderiu G, Padró T. et al. CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event. Int J Cardiol. 2016 Apr 1;208:147-9. doi: 10.1016/j.ijcard.2016.01.211ca
- dc.identifier.doi http://dx.doi.org/10.1016/j.ijcard.2016.01.211
- dc.identifier.issn 0167-5273
- dc.identifier.uri http://hdl.handle.net/10230/27086
- dc.language.iso catca
- dc.publisher Elsevierca
- dc.relation.ispartof International Journal of Cardiology. 2016 Apr 1;208:147-9
- dc.rights © Elsevier. http://dx.doi.org/10.1016/j.ijcard.2016.01.211
- dc.rights.accessRights info:eu-repo/semantics/openAccessca
- dc.subject.other Sistema cardiovascular -- Malaltiesca
- dc.subject.other Limfòcitsca
- dc.title CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event.ca
- dc.type info:eu-repo/semantics/articleca
- dc.type.version info:eu-repo/semantics/acceptedVersionca